ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MHC Myhealthchecked Plc

10.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Myhealthchecked Plc LSE:MHC London Ordinary Share GB00BN7K5L93 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 9.50 10.50 10.00 9.63 10.00 0.00 08:00:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 22.31M 1.52M 0.0292 3.42 5.2M

Concepta PLC Director Shareholding (0820J)

26/06/2017 7:00am

UK Regulatory


Myhealthchecked (LSE:MHC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Myhealthchecked Charts.

TIDMCPT

RNS Number : 0820J

Concepta PLC

26 June 2017

26 June 2017

Concepta plc

("Concepta" or the "Company")

Director Shareholding

Concepta plc (AIM:CPT), announces that Erik Henau, Chief Executive Officer of the Company, has purchased 80,000 Ordinary Shares at a price of 12.175 per share.

Subsequent to this purchase, Erik Henau is interested in 293,333 Ordinary Shares, representing 0.267% of Concepta's issued ordinary share capital.

The notification below is made in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 
 1    Details of the person discharging managerial responsibilities/person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                               Erik Henau 
---  ----------------------------------------------------------------  ----------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                   Chief Executive Officer 
---  ----------------------------------------------------------------  ----------------------------- 
 b)   Initial notification/Amendment                                    Initial notification 
---  ----------------------------------------------------------------  ----------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                              Concepta plc 
---  ----------------------------------------------------------------  ----------------------------- 
 b)   LEI 
---  ----------------------------------------------------------------  ----------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument 
       Identification code 
---  ----------------------------------------------------------------  ----------------------------- 
 b)   Nature of the transaction                                         Purchase of Ordinary Shares 
---  ----------------------------------------------------------------  ----------------------------- 
 c)   Price(s) and volume(s)                                             Price(s)      Volume(s) 
                                                                         ------------  ---------- 
                                                                          GBP0.12175    80,000 
                                                                         ------------  ---------- 
---  ----------------------------------------------------------------  ----------------------------- 
 d)   Aggregated information -   Aggregated volume 
           ------------------ 
        -   Price 
           ------------------ 
---  ----------------------------------------------------------------  ----------------------------- 
 e)   Date of the transaction                                           2017-06-22 
---  ----------------------------------------------------------------  ----------------------------- 
 f)   Place of the transaction                                          London 
---  ----------------------------------------------------------------  ----------------------------- 
 

Enquiries:

Concepta plc

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

SPARK Advisory Partners Limited (NOMAD)

Neil Baldwin / Mark Brady

Tel: +44 (0)20 368 3550

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles / Joe Burgess

Tel: +44 (0) 7748 843 871

About Concepta Plc:

Concepta plc is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*.

Founded in 2013, Concepta has developed a revolutionary flagship product 'myLotus' for home self-testing that helps women with unexplained infertility to conceive.

myLotus is the only consumer product which allows both quantitative and qualitative measurements of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Competitor products currently only allow qualitative measurement and are based on the 'average woman'.

Concepta has a defined route to market for its new 'myLotus' product with Regulatory approvals for launch in China in place for H1 2017 and CE-Marking for UK and Europe to follow later in 2017. The revenue potential of the Chinese and EU infertility market is worth c.GBP600m per annum for the company.

*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSEEEFIFWSEDM

(END) Dow Jones Newswires

June 26, 2017 02:00 ET (06:00 GMT)

1 Year Myhealthchecked Chart

1 Year Myhealthchecked Chart

1 Month Myhealthchecked Chart

1 Month Myhealthchecked Chart

Your Recent History

Delayed Upgrade Clock